LATEST LYMPHOMAS CONTENT

Navigating CAR T-Cell Therapy Decisions in Relapsed B-Cell Lymphoma

Drawing Comparisons for Relevant Therapies in Patients With DLBCL

Hematologists Should Consider What Comes Next for Patients With DLBCL

Community Oncologists Show Comfort With Bispecifics in B-Cell Lymphoma

Later-Line CD19 and Bispecific Therapies Considered After CAR T

Participants Discuss LOTIS-2 Data Based on Patient Case of DLBCL

Different Options Discussed for DLBCL in Later-Lines of Treatment

Experience and Sequencing Guide Third-Line DLBCL Therapy Selection
CASE-BASED ROUNDTABLES
Advertisement
Advertisement






